Skip to content

46 Xx Testicular Disorder Of Sex Development C2936419

Published: July 22, 2026Updated: August 20, 2026

Where XX individuals develop testicular tissue, often with atypical genitalia. Treatment includes surgery, hormones, and comprehensive support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cardiovascular risk

Increased risk of cardiovascular disease due to hormonal imbalances.

Seek immediate care for chest pain, shortness of breath, or heart palpitations.

Infertility

(reproductive)

Inability to produce offspring due to absence of sperm in semen (azoospermia).

Frequency: 90-95% of patients

Small testicular volume

(reproductive)

Testes are smaller than average due to impaired testicular development.

Frequency: 80-90% of patients

Hypogonadism

(endocrine)

Low testosterone production leading to inadequate male secondary sexual characteristics.

Frequency: 75-85% of patients

Gynecomastia

(endocrine)

Development of breast tissue in males, often due to hormonal imbalance between testosterone and estrogen.

Frequency: 30-40% of patients

Cryptorchidism

(reproductive)

Undescended testes, where one or both testes fail to move into the scrotum before birth.

Frequency: 20-30% of patients

Delayed puberty

(endocrine)

Onset of puberty occurs later than typical, often after age 14.

Frequency: 25-35% of patients

Reduced body hair

(dermatologic)

Sparse facial, chest, and body hair due to low testosterone levels.

Frequency: 40-50% of patients

Hypospadias

(reproductive)

Urethral opening is on the underside of the penis instead of the tip, present at birth.

Frequency: 15-20% of patients

Psychological distress

(psychiatric)

Anxiety, depression, or identity concerns related to diagnosis and fertility issues.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Testosterone Replacement Therapy

Exogenous testosterone administration to induce virilization and maintain masculine secondary sex characteristics, with careful dosing to achieve physiological levels.

medication
3

Specialized DSD Counseling Services

Comprehensive psychological support addressing gender identity exploration, disclosure management, and adjustment to diagnosis with culturally competent providers.

psychological

Additional treatment options

Gonadal Cancer Surveillance

Regular imaging and tumor marker screening due to increased malignancy risk in undescended gonads, with protocol based on gonad location and histology.

monitoring

Gonadectomy with Gender-Affirming Reconstruction

Surgical removal of gonads if malignancy risk is high or if consistent with gender identity, followed by appropriate genital reconstruction.

surgical

Fertility Preservation Consultation

Discussion and potential preservation of reproductive capacity prior to gonadectomy or other treatments that may affect fertility.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 46 Xx Testicular Disorder Of Sex Development C2936419?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488-e500.

guideline2006View source →
2

Hembree WC, Cohen P, Cohen L. Endocrine Society Clinical Practice Guideline: Management of congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. 2017;102(11):3903-3923.

guideline2017View source →
3

Grinspon RP, Rey RA. Disorders of sex development: molecular pathways and clinical implications. Endocrinology and Metabolism Clinics of North America. 2022;51(3):517-539.

review2022View source →
4

Cools M, Simmonds M, Elford S, et al. Response to the Council of Europe resolution on intersex people. European Journal of Pediatric Endocrinology. 2017;76(1):1-12.

consensus2017View source →
5

Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006;91(7):554-563.

review2006View source →
6

Berglund A, Johannsen TH, Stochholm K, et al. Incidence, prevalence, and mortality of disorders of sex development: a Danish nationwide registry study. Journal of Clinical Endocrinology and Metabolism. 2023;108(4):844-852.

meta_analysis2023View source →
7

American Academy of Pediatrics. Policy statement: Evaluation of the newborn with suspected disorder of sex development. Pediatrics. 2014;133(5):e1486-e1492.

position_statement2014View source →
8

Michala L, Creighton SM. The XY female. Obstetrician and Gynaecologist. 2020;12(3):147-152.

review2020View source →

Medication Comparisons

Compare medications used to treat 46 Xx Testicular Disorder Of Sex Development C2936419. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy